Evidence map›Paper›PMID 25663250›Full record

ReviewSports medicine (Auckland, N.Z.)2015

Performance-enhancing substances in sports: a review of the literature.

Amit Momaya, Marc Fawal, Reed Estes

Abstract readReview
PubMed Publisher
In one paragraph

Review in Sports medicine (Auckland, N.Z.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Curiositas.The Ulster medical journal · 2023
    Article
  8. Prevalence of dietary supplement consumption among CrossFit practitioners.Nutrire : revista de Sociedade Brasileira de Alimentacao e Nutricao = journal of the Brazilian Society of Food and Nutrition · 2023
    Article
  9. Review
  10. Article
  11. Validation of theSubstance use & misuse · 2022
    Article
  12. Article
  13. Motivators of Indiscriminate and Unsafe Supplement Use among Young Australians.International journal of environmental research and public health · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. The health-related determinants of eating pattern of high school athletes in Goiás, Brazil.Archives of public health = Archives belges de sante publique · 2020
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Amit MomayaUniversity of Alabama at Birmingham, 1313 13th Street South, Birmingham, AL, 35205, USA, amit.momaya@gmail.com.
Marc Fawal
Reed Estes

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Performance-enhancing substances (PESs) have unfortunately become ubiquitous in numerous sports, often tarnishing the spirit of competition. Reported rates of PES use among athletes are variable and range from 5 to 31%. More importantly, some of these substances pose a serious threat to the health and well-being of athletes. Common PESs include anabolic-androgenic steroids, human growth hormone, creatine, erythropoietin and blood doping, amphetamines and stimulants, and beta-hydroxy-beta-methylbutyrate. With recent advances in technology, gene doping is also becoming more conceivable. Sports medicine physicians are often unfamiliar with these substances and thus do not routinely broach the topic of PESs with their patients. However, to effect positive change in the sports community, physicians must educate themselves about the physiology, performance benefits, adverse effects, and testing methods. In turn, physicians can then educate athletes at all levels and prevent the use of potentially dangerous PESs.

Indexed as

Patient Education as TopicPhysician's RoleAthletic PerformanceCompetitive BehaviorDoping in SportsHumansPerformance-Enhancing SubstancesPrevalencePerformance-Enhancing Substances

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.